Lisa Serrano, PharmD Board Member Programs Committee Chair NHPA
PANELISTS:
Diana De Vore, PharmD, MPH Ambulatory Care Pharmacist Chronic Conditions Department Kaiser Permanente
Robert Mueller, PharmD, BCPS Associate Professor of Pharmacy Practice Concordia University Wisconsin School of Pharmacy
MODERATOR:
Jerry Ayala, PharmD, MBA District Health Leader CVS Health
Learning Objectives
At the completion of this activity, pharmacists will be able to:
Recall the need for cardiovascular disease management in Hispanic/LatinX patients.
Summarize various initiatives or interventions relevant to the prevention or management of cardiovascular diseases in Hispanic/LatinX patients.
Describe several challenges and considerations for the management of heart failure in Hispanic/LatinX patients.
CONTINUING EDUCATION CREDIT
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 1.0 live contact hour (0.1 ceus) for the educational activity. No partial credit is available. UNIVERSAL ACTIVITY NUMBER (UAN): 0060-9999-21-020-L01-P
PROGRAM EVALUATION
All participants will have the opportunity to evaluate the educational session and speaker and to identify future educational needs.
REQUIREMENTS FOR CE CREDIT
A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date (5/19/2021) in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.